India, Sept. 16 -- Beta Bionics, Inc. (BBNX) is up 5.93 percent, gaining $1.14 to $20.37 on Wednesday. The move comes after the company announced the pricing of an underwritten public offering expected to generate $150 million in gross proceeds before underwriting discounts, commissions and other offering expenses.
Beta Bionics is currently trading at $20.37, up from the previous close of $19.23 after opening at $18.70 on the Nasdaq. The stock has traded between $18.62 and $21.00 during the session, with trading volume at 2.59 million shares versus average volume of 1.16 million.
googletag.cmd.push(function() { googletag.display('div-gpt-ad-1568189509843-0'); });
The offering includes 7,652,175 common shares priced at $17.25 per share an...